封面
市场调查报告书
商品编码
1741516

早产和胎膜早破检测市场(按产品类型、检测类型、最终用户和地区划分)

Preterm Birth and PROM Testing Market, By Product Type, By Test Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

早产和胎膜早破检测市场规模预计在 2025 年达到 19.2 亿美元,预计到 2032 年将达到 29.4 亿美元,2025 年至 2032 年的复合年增长率为 6.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 19.2亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 6.30% 2032年价值预测 29.4亿美元

早产,又称早产,是全球性的健康问题。早产是指妊娠37週前出生的婴儿。根据世界卫生组织(WHO)的数据,每年约有1500万个婴儿早产,约占全球每10个新生儿中就有1个。早产可导致各种健康併发症,是新生儿死亡和发病的主要原因之一。

PROM 检测是胎膜早破(Pre-labor Rupture of Membranes)的缩写,是评估早产风险的重要诊断工具。它有助于在分娩开始前及早发现胎膜破裂。透过检测羊水的存在,PROM 检测可以帮助医护人员就早产风险孕妇的管理和照护做出明智的决策。

市场动态:

早产和胎膜早破(PROM)检测市场的主要驱动力是全球早产发生率的上升。孕妇高龄、多胎妊娠、产前护理不佳、感染疾病以及社会经济因素等因素都导致了早产率的上升。胎膜早破检测在识别早产风险方面发挥关键作用,使医疗保健专业人员能够及时介入并改善新生儿的预后。

然而,有几个因素阻碍了市场的成长,包括PROM检测套组成本高、开发中地区医疗设施有限、以及孕妇和医疗保健专业人员对早产和PROM检测的认识低。

然而,由于PROM检测技术的进步、对就地检验关注以及个人化医疗需求的不断增长,市场蕴藏着巨大的商机。市场开发者正在投资研发活动,以开发出更精准、更易用、更具成本效益的创新PROM检测套组。

总体而言,早产和胎膜早破(PROM)检测市场正在经历显着增长,这得益于人们对早产的认识不断提高、胎膜早破检测方法的进步,以及早期早期疗育和干预以改善新生儿预后的需求。市场相关人员正在製定策略,以扩大产品系列,与关键相关人员合作,并探索尚未开发的市场潜力。

本研究的主要特点

  • 本报告对全球早产和胎膜早破检测市场进行了详细分析,并以 2024 年为基准年,展示了预测期 2025-2032 的市场规模和復合年增长率。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数,介绍了全球早产和胎膜早破检测市场的主要企业概况。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
  • 全球早产和胎膜早破检测市场报告涉及该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球早产和胎膜早破检测市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品类型发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4.早产和胎膜早破检测市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年早产及胎膜早破检测市场(依产品类型)

  • 套件和试剂
  • 装置
  • 耗材

6. 2020 年至 2032 年早产及胎膜早破 (PROM) 检测市场(依检测类型)

  • 骨盆腔检查
  • 超音波
  • 子宫监测
  • 生物标记检测
  • 其他的

7. 早产和胎膜早破检测市场(依最终用户划分),2020 年至 2032 年

  • 医院
  • 诊断实验室
  • 门诊
  • 研究中心
  • 其他的

8. 2020 年至 2032 年早产及胎膜早破检测市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 日本
      • 印度
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第九章 竞争态势

  • Abbott Laboratories
  • Biosynex
  • Qiagen NV
  • Clinical Innovations, LLC
  • Sera Prognostics
  • Hologic, Inc.
  • IQ Products
  • NX Prenatal, Inc.
  • Promega Corporation
  • Insight Pharmaceuticals LLC
  • Creative Diagnostics

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6403

Preterm Birth and PROM Testing Market is estimated to be valued at USD 1.92 Bn in 2025 and is expected to reach USD 2.94 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.92 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.30% 2032 Value Projection: USD 2.94 Bn

Preterm birth, also known as premature birth, is a significant global health concern. It refers to the birth of a baby before 37 completed weeks of gestation. According to the World Health Organization (WHO), around 15 million babies are born prematurely each year, accounting for approximately one in 10 births worldwide. Preterm birth can lead to various health complications and is one of the leading causes of neonatal mortality and morbidity.

PROM testing, which stands for prelabor rupture of membranes, is an important diagnostic tool used to assess the risk of preterm birth. It helps in the early detection of membrane rupture before the onset of labor. By detecting the presence of amniotic fluid, PROM testing helps healthcare professionals make informed decisions regarding the management and care of pregnant women at risk of premature birth.

Market Dynamics:

The preterm birth and PROM testing market is primarily driven by the increasing incidence of preterm births worldwide. Factors, such as maternal age, multiple pregnancies, poor prenatal care, infections, and socioeconomic factors, contribute to the rise in preterm births. PROM testing plays a crucial role in identifying the risk of preterm birth, enabling healthcare professionals to provide timely interventions and improve neonatal outcomes.

However, there are certain restraints that can hinder the growth of the market. These include the high cost of PROM testing kits, limited access to healthcare facilities in developing regions, and the lack of awareness about preterm birth and PROM testing among pregnant women and healthcare providers.

On the other hand, there are significant opportunities in the market, driven by technological advancements in PROM testing methods, increasing focus on point-of-care testing, and the growing demand for personalized medicine. Market players are investing in research and development activities to develop innovative PROM testing kits with improved accuracy, ease of use, and cost-effectiveness.

Overall, the preterm birth and PROM testing market is witnessing substantial growth, driven by the increasing awareness about preterm birth, advancements in PROM testing methods, and the need for early detection and intervention to improve neonatal outcomes. Market players are strategizing to expand their product portfolios, collaborate with key stakeholders, and explore the untapped market potential.

Key Features of the Study:

  • This report provides an in-depth analysis of the global preterm birth and PROM testing market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preterm birth and PROM testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, Hologic, Inc., IQ Products, NX Prenatal, Inc., PROMega Corporation, Insight Pharmaceuticals LLC, and Creative Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global preterm birth and PROM testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preterm birth and PROM testing market

Detailed Segmentation:

  • By Product Type
    • Kits and Reagents
    • Instruments
    • Consumables
  • By Test Type
    • Pelvic exam
    • Ultrasound
    • Uterine monitoring
    • Biomarker testing
    • Others
  • By End User
    • Hospitals
    • Diagnostics laboratories
    • Outpatient clinics
    • Research centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Abbott Laboratories
    • Biosynex
    • Qiagen Sciences LLC
    • Clinical Innovations, LLC
    • Sera Prognostics
    • Hologic, Inc.
    • IQ Products
    • NX Prenatal, Inc.
    • Promega Corporation
    • Medical predictive Technologies Inc.
    • Creative Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Preterm Birth And PROM Testing Market, By Product Type
    • Preterm Birth And PROM Testing Market, By Test Type
    • Preterm Birth And PROM Testing Market, By End User
    • Preterm Birth And PROM Testing Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of preterm births
    • High costs of prenatal diagnostic tests
    • Significant untapped potential in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Preterm Birth and PROM Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Preterm Birth and PROM Testing Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Kits and Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

6. Preterm Birth and PROM Testing Market, By Test Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pelvic exam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ultrasound
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Uterine monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Biomarker testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Preterm Birth and PROM Testing Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Diagnostics laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Outpatient clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Research centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Preterm Birth and PROM Testing Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biosynex
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clinical Innovations, LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sera Prognostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IQ Products
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NX Prenatal, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Insight Pharmaceuticals LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Creative Diagnostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us